This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Navidea Biopharmaceuticals Inc (NAVB)

AMEX: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 5.48M 32.94M 9.12M 28.64M
Receivables 816.54K 1.15M 17.60K 15.79K
Inventories 932.38K 2.23M 297.50K 821.55K
Other Current Assets 0.00 0.00 0.00 10.63K
Total Current Assets 8.60M 37.33M 10.62M 30.05M
Property, Plant & Equipment, Gross 4.12M 3.61M 2.03M 1.44M
Accumulated Depreciation & Depletion 1.61M 1.48M 1.09M 977.96K
Property, Plant & Equipment, Net 2.51M 2.13M 934.58K 463.27K
Intangibles 180.83K 136.85K 92.48K 85.42K
Other Non-Current Assets 630.49K 723.10K 327.95K 598.71K
Total Non-Current Assets 3.32M 2.99M 1.36M 1.15M
Liabilities & Shareholder Equity
Total Assets 11.92M 40.32M 11.97M 31.19M
Accounts Payable 1.48M 2.42M 1.42M 681.75K
Short Term Debt 0.00 0.00 0.00 5.57K
Other Current Liabilities 0.00 0.00 0.00 578.99K
Total Current Liabilities 9.10M 11.29M 6.19M 3.35M
Long Term Debt 29.54M 23.57M 6.93M 6.46M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 3.09M 9.46M 257.12K 257.32K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 32.63M 33.04M 7.19M 6.71M
Total Liabilities 41.72M 44.33M 13.38M 10.06M
Preferred Stock Equity 4.00 8.00 7.00 10.00
Common Stock Equity -29.80M -4.01M -1.41M 21.13M
Common Par 150.20K 135.92K 113.02K 95.40K
Additional Paid In Capital 323.03M 313.11M 273.04M 266.39M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -352.98M -317.26M -274.56M -245.36M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization -264.33K 19.56M 5.52M 27.59M
Total Equity -29.80M -4.01M -1.41M 21.13M
Total Liabilities & Stock Equity 11.92M 40.32M 11.97M 31.19M
Total Common Shares Outstanding 150.20M 135.92M 113.02M 95.40M
Preferred Shares 4.52K 7.56K 6.94K 10.08K
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 148.75M 121.81M 99.06M 90.51M
Diluted Weighted Shares Outstanding 148.75M 121.81M 99.06M 90.51M
Number of Employees 46 57 47 32
Number of Part-Time Employees 8 8 9 9

NAVB Navidea Biopharmaceuticals Inc

Chart of NAVB

Analysts Ratings for NAVB

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

NAVB Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs